Diem Nguyen

Company: Xalud Therapeutics

Job title: CEO

Seminars:

Harnessing the Power of a DNA-Delivery Platform to Address Chronic Inflammatory Diseases 12:00 pm

Advantages of DNA-Delivery, including safety, potential flexibility and manufacturing efficiency Demonstration of functionality with XT-150, addressing critical areas where other delivery modalities of IL-10 therapy have been ineffective Clinical program results for XT-150, a novel immunomodulatory gene therapy for osteoarthritis pain in Phase 2B developmentRead more

day: Track B - Day 1 AM